Cardiac resynchronization therapy (CRT) is beneficial in patients with New York Heart Association (NYHA) functional class III and IV heart failure and wide QRS duration, especially due to left bundle ...
This prospective study recruited 102 consecutive patients referred to our center for implantation of a CRT device between January and December 2005. The inclusion criteria were as follows: left ...
France: The findings of a new study published in JAMA Cardiology suggest that an electrophysiological study (EPS) provides ...
A total accident led to the discovery of a medical device that's helped extend people's lives and get a vital organ back on ...
ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results